Hims vs Wellorithm: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

53 providers verified independently·Independent research·How we rank →

Visit Wellorithm - $147/mo→or find your match

Hims beats Wellorithm overall, scoring 7.9/10 vs 7.4/10. Wellorithm is more affordable at $147/mo vs $199/mo. Choose Hims for men who want a well-known publicly-traded brand and fda-appr. Choose Wellorithm for cash-pay patients who want compounded semaglutide or tirzepa.

A side-by-side look at Hims and Wellorithm to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

Hims

#9 of 53

7.9/10

The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership, alongside their existing compounded semaglutide program. Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.

Visit Hims

Wellorithm

#29 of 53

7.4/10

Telehealth platform for compounded semaglutide and tirzepatide that uniquely offers BOTH injectable and oral dissolving tablet formats, paired with a 10% weight-loss guarantee that refunds up to four months of program fees if the patient does not lose at least 10% of baseline weight after 16 weeks of medication adherence (terms apply). 28-day recurring billing, non-refundable per-cycle, with a documented address listed in Berlin, Germany.

Visit Wellorithm

Feature	Hims	Wellorithm
Our Score	7.9/10	7.4/10
Starting Price	$199/mo	$147/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors	Cash-pay patients who want compounded semaglutide or tirzepatide in a rare oral dissolving tablet format, backed by a 10% weight-loss money-back guarantee and 24/7 support
Watch out for	Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.	Founding year, corporate ownership, and named prescribers are NOT publicly disclosed, and the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients; if disclosed leadership matters to you, weigh this first
Ranking	#9	#29
Get started	Visit Hims	Visit Wellorithm

Pros & Cons Compared

Hims

Pros

+Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
+2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
+$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
+Polished app and web experience, among the best user interfaces in men's telehealth.
+8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.

Cons

−Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
−28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
−Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
−'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
−Brand Wegovy at $599/mo is not competitive with LillyDirect/NovoCare cash prices or with Hers ($149/mo for the same product via the same Novo partnership).
−Generic high-volume support, large patient base means less personalized attention than smaller competitors.

Wellorithm

Pros

+Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats, semaglutide and tirzepatide each in two formats, broader format menu than most compounded-only platforms
+10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
+Competitive entry pricing, $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market
+2-minute qualification quiz, virtual consultation, 24/7 support availability claimed
+23,000+ reviews and 4.9-star rating reported (volume is unusually high for this market segment, verify on independent third-party sources before relying on it)
+Spring promotion advertised at $147 with free shipping included

Cons

−Founding year, corporate ownership, and named prescribers are NOT publicly disclosed, and the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients; if disclosed leadership matters to you, weigh this first
−49 states only, service is unavailable in Louisiana and outside the United States
−Billing runs on a 28-day recurring cycle and payments are non-refundable once processed, with no proration for partial months; cancel before your next cycle processes to avoid paying for an unused month
−Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo; FDA does not review compounded medications for safety, effectiveness, or manufacturing quality
−The weight-loss guarantee has strict eligibility terms: verified weight documentation (doctor attestation or video evidence), prior medication history disclosure, consistent dosing adherence, and refund processed within 30 days of approval, with only fees actually paid refundable and baseline payments non-refundable; document your starting weight from day one if you plan to rely on it
−Two different affiliate landing pages (campaign-7 and qoroxapi/lead.php direct route) run different funnel structures, so the post-click experience can vary

Our Verdict

Hims edges out Wellorithm with a score of 7.9/10 vs 7.4/10. If budget is your priority, Wellorithm starts at $147/mo compared to Hims's $199/mo. Hims offers both brand-name and compounded medications, giving you more flexibility. Choose Hims if you want: men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose Wellorithm if you want: cash-pay patients who want compounded semaglutide or tirzepatide in a rare oral dissolving tablet format, backed by a 10% weight-loss money-back guarantee and 24/7 support.

Still undecided? Editor's Featured Pick

TrimRx

$149/mo · 7.8/10 · Compounded

If neither Hims nor Wellorithm feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.

Visit TrimRx→Read our full TrimRx review